tirzepatide used for diabetes Peptide of the Week: Tirzepatide, a Game Changer Type 2 and Obesity Management Semaglutide and tirzepatide treatment leads
Description
This is the sole reason a true tirzepatide tablet doesnt exist yet
At the 5 mg weekly dose, participants lost an average of 16.0% of their body weight over 72 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Qeadan F, McCunn A, Tingey B
Both patterns are normal
Understanding this pharmacology is essential when evaluating treatment response, as the full therapeutic effect may not be apparent during the initial titration period
Treatment strategies: Maximum tolerated dose of weekly subcutaneous tirzepatide (10 or 15 mg) vs maximum tolerated dose of semaglutide (1.7 or 2.4 mg)
